BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 31207360)

  • 21. Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics.
    Yan F; Wen Z; Wang R; Luo W; Du Y; Wang W; Chen X
    BMC Pulm Med; 2017 Dec; 17(1):174. PubMed ID: 29212488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxidative Stress in Autoimmune Diseases: An Under Dealt Malice.
    Ramani S; Pathak A; Dalal V; Paul A; Biswas S
    Curr Protein Pept Sci; 2020; 21(6):611-621. PubMed ID: 32056521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic effects of BuChE non-UU phenotype and paraoxonase (PON1) 55 M allele on the risk of systemic lupus erythematosus: influence on lipid and lipoprotein metabolism and oxidative stress, preliminary report.
    Bahrehmand F; Vaisi-Raygani A; Rahimi Z; Ahmadi R; Kiani A; Tavilani H; Vaisi-Raygani H; Pourmotabbed T
    Lupus; 2014 Mar; 23(3):263-72. PubMed ID: 24399815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidative lipidomics: applications in critical care.
    Anthonymuthu TS; Kim-Campbell N; Bayır H
    Curr Opin Crit Care; 2017 Aug; 23(4):251-256. PubMed ID: 28661413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidative Stress and Lipid Mediators Modulate Immune Cell Functions in Autoimmune Diseases.
    Wójcik P; Gęgotek A; Žarković N; Skrzydlewska E
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33450863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical application of protein biomarkers in lupus erythematosus and lupus nephritis.
    Qi S; Chen Q; Xu D; Xie N; Dai Y
    Lupus; 2018 Sep; 27(10):1582-1590. PubMed ID: 29720035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipidomics Revealed Aberrant Lipid Metabolism Caused by Inflammation in Cardiac Tissue in the Early Stage of Systemic Lupus Erythematosus in a Murine Model.
    Zhang J; Lu L; Tian X; Wang K; Xie G; Li H; Wen C; Hu C
    Metabolites; 2022 May; 12(5):. PubMed ID: 35629919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Innovative Lipidomic Workflow to Investigate the Lipid Profile in a Cystic Fibrosis Cell Line.
    Dei Cas M; Zulueta A; Mingione A; Caretti A; Ghidoni R; Signorelli P; Paroni R
    Cells; 2020 May; 9(5):. PubMed ID: 32408521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accelerated atherosclerosis, immune response and autoimmune rheumatic diseases.
    Jara LJ; Medina G; Vera-Lastra O; Amigo MC
    Autoimmun Rev; 2006 Mar; 5(3):195-201. PubMed ID: 16483919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The critical role of epigenetics in systemic lupus erythematosus and autoimmunity.
    Long H; Yin H; Wang L; Gershwin ME; Lu Q
    J Autoimmun; 2016 Nov; 74():118-138. PubMed ID: 27396525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and Quantification of Oxidized Lipids in LC-MS Lipidomics Data.
    Krettler CA; Hartler J; Thallinger GG
    Stud Health Technol Inform; 2020 Jun; 271():39-48. PubMed ID: 32578539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitochondrial Fatty Acid β-Oxidation Disorders: From Disease to Lipidomic Studies-A Critical Review.
    Guerra IMS; Ferreira HB; Melo T; Rocha H; Moreira S; Diogo L; Domingues MR; Moreira ASP
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipidomics applications for discovering biomarkers of diseases in clinical chemistry.
    Zhao YY; Cheng XL; Lin RC
    Int Rev Cell Mol Biol; 2014; 313():1-26. PubMed ID: 25376488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of recent advances in lipidomics and redox lipidomics on dermatological research.
    Gruber F; Kremslehner C; Narzt MS
    Free Radic Biol Med; 2019 Nov; 144():256-265. PubMed ID: 31004751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased lipid and protein oxidation and lowered anti-oxidant defenses in systemic lupus erythematosus are associated with severity of illness, autoimmunity, increased adhesion molecules, and Th1 and Th17 immune shift.
    Scavuzzi BM; Simão ANC; Iriyoda TMV; Lozovoy MAB; Stadtlober NP; Franchi Santos LFDR; Flauzino T; de Medeiros FA; de Sá MC; Consentin L; Reiche EMV; Maes M; Dichi I
    Immunol Res; 2018 Feb; 66(1):158-171. PubMed ID: 29185130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shotgun mass spectrometry-based lipid profiling identifies and distinguishes between chronic inflammatory diseases.
    Matthiesen R; Lauber C; Sampaio JL; Domingues N; Alves L; Gerl MJ; Almeida MS; Rodrigues G; Araújo Gonçalves P; Ferreira J; Borbinha C; Pedro Marto J; Neves M; Batista F; Viana-Baptista M; Alves J; Simons K; Vaz WLC; Vieira OV
    EBioMedicine; 2021 Aug; 70():103504. PubMed ID: 34311325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive lipidomic profiling in serum and multiple tissues from a mouse model of diabetes.
    Chen Z; Liang Q; Wu Y; Gao Z; Kobayashi S; Patel J; Li C; Cai F; Zhang Y; Liang C; Chiba H; Hui SP
    Metabolomics; 2020 Oct; 16(11):115. PubMed ID: 33067714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic disturbances associated with systemic lupus erythematosus.
    Wu T; Xie C; Han J; Ye Y; Weiel J; Li Q; Blanco I; Ahn C; Olsen N; Putterman C; Saxena R; Mohan C
    PLoS One; 2012; 7(6):e37210. PubMed ID: 22723834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Focusing on tissue biomarkers. Estrogens as key players in the immune response and autoimmunity].
    Vásárhelyi B; Mészáros K; Karvaly G; Patócs A
    Orv Hetil; 2015 Dec; 156(51):2070-6. PubMed ID: 26654543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipidomics: Novel insight into the biochemical mechanism of lipid metabolism and dysregulation-associated disease.
    Zhao YY; Miao H; Cheng XL; Wei F
    Chem Biol Interact; 2015 Oct; 240():220-38. PubMed ID: 26358168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.